AgeX Therapeutics, Inc. (24) | Business Finance (19)

Browse by Subcategory

Recent Contracts

Amendment No. 3 to Registration Rights Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on February 15, 2022)
Warrant Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on February 15, 2022)
Security Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on February 15, 2022)
Secured Note dated February 14, 2022, executed by AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on February 15, 2022)
Amendment No. 2 to Loan Facility Agreement, dated November 8, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on November 9, 2021)
Second Amendment to Secured Convertible Facility Agreement, dated November 12, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on November 16, 2020)
Form of Warrant (Filed With SEC on February 15, 2022)
Amendment No. 2 to Registration Rights Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on February 11, 2021)
Amendment No. 1 to Loan Facility Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on February 11, 2021)
First Amendment to Warrant Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited, including form of warrant (Filed With SEC on August 14, 2020)
First Amendment to Secured Convertible Facility Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on August 14, 2020)
Amendment No. 1 to Registration Rights Agreement, dated March 30, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on March 30, 2020)
Warrant Agreement, dated March 30, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited, including form of warrant (Filed With SEC on March 30, 2020)
Secured Convertible Facility Agreement, dated March 30, 2020, by and among AgeX Therapeutics, Inc., ReCyte Therapeutics, Inc., Reverse Bioengineering, Inc., and Juvenescence... (Filed With SEC on March 30, 2020)
Warrant dated August 13, 2019 (Filed With SEC on August 14, 2019)
Registration Rights Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd (Filed With SEC on August 14, 2019)
Warrant Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd (Filed With SEC on August 14, 2019)
Loan Facility Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd (Filed With SEC on August 14, 2019)
Warrant Agreement, dated February 28, 2018, including form of warrant (Filed With SEC on April 1, 2019)